Clinical Trial Update: Population Pharmacokinetics of Edoxaban in Chinese Patients With Non-Valvular Atrial Fibrillation [Phase 4]

View source ↗

Summary

This Phase 4 study evaluates the population pharmacokinetics of edoxaban in Chinese patients with non-valvular atrial fibrillation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-valvular Atrial Fibrillation

Drugs mentioned

• Edoxaban (edoxaban)

Snippet

Sponsor: China National Center for Cardiovascular Diseases | Conditions: Non-Valvular Atrial Fibrillation | Phase 4 | Status: COMPLETED